WO1999030689A1 - Pharmaceutical suspension tablet compositions - Google Patents
Pharmaceutical suspension tablet compositions Download PDFInfo
- Publication number
- WO1999030689A1 WO1999030689A1 PCT/US1998/024798 US9824798W WO9930689A1 WO 1999030689 A1 WO1999030689 A1 WO 1999030689A1 US 9824798 W US9824798 W US 9824798W WO 9930689 A1 WO9930689 A1 WO 9930689A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- percent
- tablets
- microcrystalline cellulose
- pharmacologically active
- granulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU15311/99A AU1531199A (en) | 1997-12-12 | 1998-11-20 | Pharmaceutical suspension tablet compositions |
DE69838300T DE69838300T2 (en) | 1997-12-12 | 1998-11-20 | PHARMACEUTICAL SUSPENSION TABLET COMPOSITIONS |
EP98959527A EP1035838B1 (en) | 1997-12-12 | 1998-11-20 | Pharmaceutical suspension tablet compositions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/989,787 US5955107A (en) | 1997-12-12 | 1997-12-12 | Pharmaceutical suspension tablet compositions |
US08/989,787 | 1997-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999030689A1 true WO1999030689A1 (en) | 1999-06-24 |
Family
ID=25535456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/024798 WO1999030689A1 (en) | 1997-12-12 | 1998-11-20 | Pharmaceutical suspension tablet compositions |
Country Status (7)
Country | Link |
---|---|
US (1) | US5955107A (en) |
EP (1) | EP1035838B1 (en) |
AT (1) | ATE370727T1 (en) |
AU (1) | AU1531199A (en) |
DE (1) | DE69838300T2 (en) |
ES (1) | ES2293694T3 (en) |
WO (1) | WO1999030689A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU753241B2 (en) * | 1998-06-11 | 2002-10-10 | Pharmacia & Upjohn Company | Tablet formation |
WO2004006917A1 (en) * | 2002-07-16 | 2004-01-22 | Ranbaxy Laboratories Limited | Dispersible tablets for oral administration |
US8173161B2 (en) | 2002-12-04 | 2012-05-08 | Mcneil-Ppc, Inc. | Method of administering a pharmaceutical active ingredient |
WO2023101951A1 (en) * | 2021-12-03 | 2023-06-08 | Hercules Llc | An organic chewable composition comprising certified organic ingredients, and process for preparing the same |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
US6344222B1 (en) | 1998-09-03 | 2002-02-05 | Jsr Llc | Medicated chewing gum delivery system for nicotine |
US6432448B1 (en) * | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
AR028253A1 (en) * | 2000-03-16 | 2003-04-30 | Pfizer Prod Inc | INHIBITORS OF THE GLUCOGENO FOSFORILASA |
AU2001261744A1 (en) * | 2000-05-19 | 2001-12-03 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
US6544552B2 (en) | 2001-01-11 | 2003-04-08 | Particle And Coating Technologies, Inc. | Method of producing porous tablets with improved dissolution properties |
CA2472103A1 (en) * | 2002-01-25 | 2003-08-07 | Santarus, Inc. | Transmucosal delivery of proton pump inhibitors |
CA2474835A1 (en) * | 2002-02-01 | 2003-08-07 | Pfizer Products Inc. | Immediate release dosage forms containing solid drug dispersions |
WO2004014337A2 (en) * | 2002-08-02 | 2004-02-19 | Ranbaxy Laboratories Limited | A process for the preparation of dispersible tablet of cephalexin |
US20040161459A1 (en) * | 2002-12-31 | 2004-08-19 | Ngoc Do | Fast-dissolve tablet technology |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US7838029B1 (en) * | 2003-07-31 | 2010-11-23 | Watson Laboratories, Inc. | Mirtazapine solid dosage forms |
US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
CA2642761A1 (en) * | 2006-02-23 | 2007-08-30 | Iomedix Sleep International Srl | Compositions and methods for the induction and maintenance of quality sleep |
US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
ES2569925T3 (en) * | 2009-09-30 | 2016-05-13 | Acura Pharmaceuticals, Inc. | Methods and compositions of deterrence of abuse |
RU2673818C2 (en) | 2012-11-30 | 2018-11-30 | Экьюра Фармасьютикалз, Инк. | Self-regulated release of active pharmaceutical ingredient |
WO2014102802A1 (en) * | 2012-12-30 | 2014-07-03 | Hadasit Medical Research Services And Development Ltd. | Alginate compositions and uses thereof |
US9642811B2 (en) | 2014-03-26 | 2017-05-09 | Sun Pharma Advanced Research Company Ltd. | Abuse deterrent immediate release biphasic matrix solid dosage form |
US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR880701098A (en) * | 1986-04-01 | 1988-07-25 | 로버어트 에이 아미테이지 | Methylprednisolone / sodium carboxymethyl starch tablet composition |
US5073377A (en) * | 1988-11-03 | 1991-12-17 | Miles Inc. | Method of preparing oral dosage forms with a granulating composition |
US4965072A (en) * | 1988-11-03 | 1990-10-23 | Miles Inc. | Granulating composition and method |
ATE133068T1 (en) * | 1991-01-30 | 1996-02-15 | Wellcome Found | WATER SOLUBLE TABLETS |
US5370878A (en) * | 1993-09-30 | 1994-12-06 | Hallmark Pharmaceuticals, Inc. | Method for preparing a direct compression granulated acetaminophen composition |
EP0804169A4 (en) * | 1994-12-01 | 1998-08-19 | Cibus Pharmaceutical Inc | Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants |
GB9603699D0 (en) * | 1996-02-21 | 1996-04-17 | Boots Co Plc | Therapeutic composition |
US5858409A (en) * | 1996-04-17 | 1999-01-12 | Fmc Corporation | Hydrolyzed cellulose granulations for pharmaceuticals |
-
1997
- 1997-12-12 US US08/989,787 patent/US5955107A/en not_active Expired - Fee Related
-
1998
- 1998-11-20 EP EP98959527A patent/EP1035838B1/en not_active Expired - Lifetime
- 1998-11-20 DE DE69838300T patent/DE69838300T2/en not_active Expired - Fee Related
- 1998-11-20 WO PCT/US1998/024798 patent/WO1999030689A1/en active IP Right Grant
- 1998-11-20 ES ES98959527T patent/ES2293694T3/en not_active Expired - Lifetime
- 1998-11-20 AU AU15311/99A patent/AU1531199A/en not_active Abandoned
- 1998-11-20 AT AT98959527T patent/ATE370727T1/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU753241B2 (en) * | 1998-06-11 | 2002-10-10 | Pharmacia & Upjohn Company | Tablet formation |
AU753241C (en) * | 1998-06-11 | 2003-05-08 | Pharmacia & Upjohn Company | Tablet formation |
WO2004006917A1 (en) * | 2002-07-16 | 2004-01-22 | Ranbaxy Laboratories Limited | Dispersible tablets for oral administration |
US8173161B2 (en) | 2002-12-04 | 2012-05-08 | Mcneil-Ppc, Inc. | Method of administering a pharmaceutical active ingredient |
WO2023101951A1 (en) * | 2021-12-03 | 2023-06-08 | Hercules Llc | An organic chewable composition comprising certified organic ingredients, and process for preparing the same |
Also Published As
Publication number | Publication date |
---|---|
DE69838300D1 (en) | 2007-10-04 |
EP1035838A1 (en) | 2000-09-20 |
ATE370727T1 (en) | 2007-09-15 |
AU1531199A (en) | 1999-07-05 |
US5955107A (en) | 1999-09-21 |
ES2293694T3 (en) | 2008-03-16 |
DE69838300T2 (en) | 2008-05-15 |
EP1035838B1 (en) | 2007-08-22 |
EP1035838A4 (en) | 2006-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5955107A (en) | Pharmaceutical suspension tablet compositions | |
EP1058538B2 (en) | Fast disintegrating tablets | |
EP0305051B1 (en) | Orally sustained-release acetaminophen formulation and process to obtain it | |
US6238695B1 (en) | Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants | |
US6955821B2 (en) | Sustained release formulations of guaifenesin and additional drug ingredients | |
FI117962B (en) | The method provides a solid oral dosage form and a filler | |
JPH01250314A (en) | Gradual release agent | |
JP2015147812A (en) | Method for producing orally disintegrating tablet | |
JPH06316536A (en) | Taste-masking and sustained-release film for medicine | |
JPH0669965B2 (en) | Solid sustained release pharmaceutical formulation | |
WO1994003158A1 (en) | Solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof | |
IE883583L (en) | Spray dried ibuprofen | |
AU2008245597A1 (en) | Solid dosage forms | |
JPH09500910A (en) | Film-coated tablets of paracetamol and domperidone | |
JPH05246861A (en) | Polycarbophyllcalcium-containing pharmaceutical | |
JP3836893B2 (en) | Polycarbophil calcium-containing preparation | |
EP0599767B1 (en) | Process to prepare water-dispersable tablets containing diclofenac | |
CA1334933C (en) | Pharmaceutical composition and process for its preparation | |
JP2012046454A (en) | Tablet for internal use and method for producing the same | |
JP4842960B2 (en) | Method for producing a compressed solid dosage form well suited for use with low water-soluble drugs and compressed solid dosage form produced thereby | |
UA79567C2 (en) | Orodispersible pharmaceutical composition of antithrombolic compound | |
KR20010072577A (en) | Stabile compositions comprising levosimendan and alginic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998959527 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998959527 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998959527 Country of ref document: EP |